Search research articles
Contact Us
Filters
Showing results (351-360 of 373) with videos related to
Page
of 38
Sort By:
Blood
|
July 5, 2017
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
Lori Muffly, Marcelo C Pasquini, Michael Martens, et al.
Leukemia
|
October 31, 2022
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
Bone Marrow Transplantation
|
May 6, 2022
Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation
Rachel Phelan, Annie Im, Rebecca L Hunter, et al.
Transplantation and Cellular Therapy
|
August 17, 2021
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes
Betül Oran, Kwang Woo Ahn, Caitrin Fretham, et al.
Leukemia Research
|
November 3, 2017
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs
Allison H Scotch, Heidi Kosiorek, Robyn Scherber, et al.
Transplantation and Cellular Therapy
|
November 10, 2021
Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation
Rachel Phelan, Annie Im, Rebecca L Hunter, et al.
JAMA Oncology
|
January 13, 2022
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors
Guru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, et al.
Haematologica
|
August 20, 2016
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group
Holly L Geyer, Heidi Kosiorek, Amylou C Dueck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 2, 2015
Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies
Marcelo C Pasquini, Mei-Jie Zhang, Bruno C Medeiros, et al.
Blood Advances
|
May 3, 2023
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis
Roni Tamari, Donal P McLornan, Kwang Woo Ahn, et al.
Page
of 38
Search research articles
Search
Showing results (351-360 of 373) with videos related to
Sort By:
Page
of 38
Blood
|
July 5, 2017
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
Lori Muffly, Marcelo C Pasquini, Michael Martens, et al.
Leukemia
|
October 31, 2022
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
Bone Marrow Transplantation
|
May 6, 2022
Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation
Rachel Phelan, Annie Im, Rebecca L Hunter, et al.
Transplantation and Cellular Therapy
|
August 17, 2021
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes
Betül Oran, Kwang Woo Ahn, Caitrin Fretham, et al.
Leukemia Research
|
November 3, 2017
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs
Allison H Scotch, Heidi Kosiorek, Robyn Scherber, et al.
Transplantation and Cellular Therapy
|
November 10, 2021
Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation
Rachel Phelan, Annie Im, Rebecca L Hunter, et al.
JAMA Oncology
|
January 13, 2022
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors
Guru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, et al.
Haematologica
|
August 20, 2016
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group
Holly L Geyer, Heidi Kosiorek, Amylou C Dueck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 2, 2015
Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies
Marcelo C Pasquini, Mei-Jie Zhang, Bruno C Medeiros, et al.
Blood Advances
|
May 3, 2023
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis
Roni Tamari, Donal P McLornan, Kwang Woo Ahn, et al.
Page
of 38